AVXL Anavex Life Sciences Corp.

+0.13  (2%)
Previous Close 5.81
Open 5.77
Price To book 11.19
Market Cap 245.77M
Shares 41,376,000
Volume 271,616
Short Ratio 8.16
Av. Daily Volume 393,795

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 planned for 2017.
Rett syndrome
Phase 2a 12-month data released December 8, 2016. Trial is ongoing. Additional Phase 2/3 trial planned for 2017.
Mild to moderate Alzheimer’s disease

Latest News

  1. Zacks.com featured highlights: Anavex Life Sciences, Kinross Gold, LightPath Technologies, MFA Financial and Student Transportation
  2. Explosive Stocks Under $10
  3. Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Presented at Antiepileptic Drug Trials XIV 2017 Conference
  4. Anavex Life Sciences reports 2Q loss
  5. Anavex Reports Fiscal Second Quarter 2017 Financial Results
  6. Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs
  7. Can Anavex (AVXL) Run Higher on Strong Earnings Estimate Revisions?
  8. For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
  9. Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor
  10. Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
  11. Anavex Life Sciences to Present at the 13th International Conference on Alzheimer's and Parkinson's Diseases AD/PD™ 2017
  12. Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
  13. Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference
  14. Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference
  15. 3 Companies That Might Not Live to See 2020
  16. 3 Companies Looking to Capitalize on Orphan Designation with Multiple Catalyst
  17. Here's Why Anavex Life Sciences Corp. Surged Today
  18. Noble Capital Markets Initiates Research Coverage on Anavex Life Sciences Corp. (AVXL)